The efficacy and safety of ustekinumab in adolescents newly diagnosed with type 1 diabetes: the USTEK1D RCT

Background Type 1 diabetes is an autoimmune disease affecting over 400,000 children and adults in the United Kingdom for which currently the only available therapy is insulin. Objective(s) To determine the efficacy and safety of the monoclonal antibody ustekinumab targeting the interleukin 12/interl...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Kymberley Carter, Wai-Yee Cheung, Hayley A Hutchings, Greg Fegan, Gail Holland, Steve Luzio, Gareth Dunseath, Stephen Hiles, Susie Marques-Jones, John W Gregory, Danijela Tatovic, Peter Taylor, Jane Bowen-Morris, Rachel Stenson, Stephanie Hanna, Zainab Mahmood, Jennie Yang, Evangelia Williams, Timothy Tree, Ashish Marwaha, Colin M Dayan
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	NIHR Journals Library 2025-02-01
Schriftenreihe:	Efficacy and Mechanism Evaluation
Schlagworte:	diabetes mellitus type 1 randomised controlled trial ustekinumab c-peptide
Online-Zugang:	https://doi.org/10.3310/FQLN7416
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!